Navigation Links
Georgia: Indian doctor's license cancelled

A 70-year-old Indian-American doctor’s licence has been suspended by the Medical Board of Georgia state for allegedly using insecticides to treat cancer patients // and prescribing unauthorised drugs.

The nine-member board took the unanimous decision at a meeting on Thursday.

The board's action came after a federal grand jury had accused Totada R Shanthaveerappa, a practitioner in Stockbridge, earlier this week, of using weed killer and insecticide to treat patients. The jury had returned an 87-count indictment accusing him of falsely billing insurance companies that he was using approved drugs.

In its order, the state board cited the case of a cancer patient treated by Shanthaveerappa in 2001. It said the 70-year-old doctor treated the patient with a chemotherapy drug called methotrexate in doses so high they posed "an unreasonable and significant risk to the patient who subsequently died from complications caused by the methotrexate".

The board said it had received a letter from Shanthaveerappa on Thursday acknowledging that he had treated patients with two drugs not approved for use in the United States and that he misbranded one of the drugs.

Prosecutors claim that Shanthaveerappa and his assistant, Dan Bartoli, injected numerous patients with unapproved and misbranded drugs, including Dinithrophenol, a weed killer and other insecticides. The two men also submitted false insurance claims, which disguised the types of drugs and treatments they were providing.

Shanthaveerappa has not been arrested. His lawyer Donaway said the doctor plans to plead not guilty when he appears in court on Tuesday.

Sources in the law enforcement agency said they expect him to surrender within the next few days.

Shanthaveerappa, who has been licensed to practice since 1972, can appeal the medical board's decision before a state administrative law judge or the state Supreme Court.

Shanthaveerappa
'"/>




Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Indian Doctor granted US patent on organ regeneration
4. Heart attack kills one in every 10 Indians
5. Indian Cherry: Richest Source of Vitiamin C
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. An Indian Bride with signs of SARS
8. Are Indians aware of SARS ?
9. Indians Stay Away from Coke, Pepsi After Toxin Scare
10. Indian pharma industry upbeat on WTO drug deal
11. Indian Treatment for Iraqi Babies
Post Your Comments:
(Date:7/8/2008)... DETROIT, July 8 /PRNewswire-USNewswire/ -- The... it has signed an agreement with Meadowbrook C,Man...Meadowbrook Medical,Center, located in Novi, Michi...ll allow Karmanos to expand its outreach to cancer... as well as provide access to radiation,oncology, ...
(Date:7/8/2008)... Recently identified genetic markers, called sing...iated with a small but statistically significant i... to substantially improve the accuracy of existing...dividual,s risk, according to a study in the July ...cer Institute . , Risk prediction models provide...
(Date:7/8/2008)... PITTSBURGHUniversity of Pittsburgh-led researche...ongenital circulatory problemsaortic arch deformit... humans, as reported in the June 15 edition of De...sistant professor of biological sciences in Pitt,s... first complete published description of how aorti...
(Date:7/8/2008)...Study says Medicare Modernization Act yet to show ... , TUESDAY, July 8 (HealthDay News) -- Chemothera...ederal legislation that has reduced reimbursements...nds. , Critics feared the passing of the Medica...more difficult, but investigators from the Duke Cl...
Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Partners With Meadowbrook to Expand Outreach and Access for Cancer Services 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Pitt-led research provides insight into development of congenital circulatory defects 2Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2
...e affected more than 50% of the patients with skin... are also not following the norms to// prescribe t...re the infection before prescribing antibiotics bu...h strain causing the infection will be susceptible...
... Ruby had never been on a date, much less had a bo... any type of intimacy, even with family// and life...t The Methodist Hospital Weight Management Center ...timacy is not sex. Intimacy is sensuality, sexuali...
...e efficacy of smoke alarms has suggested that high... elderly. The research conducted on 42// adults, b...quency signal showed better results than a complet...oke alarms use. Data from the National Fire Prot...
...ting berries may be good for mental health althoug... these applications towards humans.// Researchers...versity have studied 60 young male rats, after spl...ls of the study have been reported in the online e...
Other Medicine News:
(Date:7/3/2008)...RUNSWICK, N.J., July 3 /- S...ny") (Amex: SNT ) announced today,that it has con...") to,supply the plasmid portion of the Company,s ...ne and siRNA against Factor 5A., Senesco has prev...ts,using its combination siRNA and plasmid against...
(Date:7/2/2008)...cified Primary Efficacy Endpoint Met in Stage 1 of... -, - 100% of Evaluable Patients to Date Continu...ponse or Stable Disease -, TUSTIN, Calif., July 2...ls, Inc. (Nasdaq: PPHM ) today reported that its ...e-specified Stage 1 primary endpoint,in its ongoin...
(Date:7/1/2008)...DELPHIA, July 1 /PRNewswire-USNewswire/ -- Researc... role in some varieties of adult,rheumatoid arthri...ritis.,The researchers say the responsible gene ma...litating disease., Researchers at The Children,s ...een the gene region and juvenile idiopathic arthri...
(Date:7/1/2008)...NKI, July 1 /- The emergence of multi...ated the use of polymyxins as the agents,of last r...hern Antibiotics,Ltd, a Finnish biotech company, h...early preclinical studies show signs of lower neph...ve charges only, while polymyxin B,and colistin ha...
Breaking Medicine Technology:Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 2Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 3Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity 2Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 1Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 2Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 3Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 4Naviscans PEM Flex 28TM 29 Scanner Shows Promising New Data in Breast Cancer Management 8191 1Naviscans PEM Flex 28TM 29 Scanner Shows Promising New Data in Breast Cancer Management 8191 2SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth 8189 1PartsSource Named 2007 Weatherhead 100 Award Winner 8187 1
..., U.K. 2nd July 2007 - CeNeS Pharmaceuticals (AIM:...d biopharmaceutical,company today announced that a... supports the hypothesis that a,catechol-O-methylt... would be a useful agent to address profound cogni...r. CeNeS has an,ongoing discovery programme to dev...
...uctions Observed at Eight Weeks Sustained up to 12...TH SAN FRANCISCO, Calif., July 02, 2007,/PRNewswir...iminary,longer-term, follow-up results from a Phas...TM) (formerly 4975) in patients with,moderate-to-s...ial,reductions in pain that persisted for up to 12...
Other Medicine Technology:Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 2Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 3Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 5
... and best value in high performance electronic pip...htweight design reduce hand fatigue and strain , S...or , Color coding for easy volume identification ,... use Hamilton AdvanTip Low Retention and AdvanTip ...
The Finnpipette BioControl multichannel has the same innovative features as the single channel model.The same universal handle fits all seven multichannel and five single channel tip cone modules. Bo
...Pipette is ideal for all liquid handling applicati... ergonomically-placed operating buttons, and vario...sing, reverse pipetting and diluting make this a l...ctions of a manual pipette without any adverse eff...
...lleled Comfort Pick one of our pipettors up and u...ejector positionsright where they should beeven if...e ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand Start dis...
Medicine Products: